Unified Community Action For A TB-Free Africa Kicks Off

Press Release:

The Africa Coalition on Tuberculosis (ACT!), whose inception was the result of a Declaration made in Washington, DC, USA in March 2012, kicked off activities at a week-long planning meeting in June in Tirano, Italy. Founding members of the coalition include tuberculosis (TB) advocates representing organizations in Zambia, Nigeria, Uganda, Kenya, Malawi, and Zimbabwe, with plans to expand and include all of Africa as the organization grows.

TB R&D Weekly Update: Results from First Novel Regimen Trial Published

Yesterday, efficacy data from the first novel regimen trial (NC001) were published in the Lancet. The results found that the regimen containing PA-824, moxifloxacin, and pyrazinamide, could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments. Click here to read the full press release.

Call for TB REACH Wave 3 Proposals

TB REACH, an initiative of the Stop TB Partnership to promote early and increased TB case detection, today has launched its call for applications for Wave 3 funding. Partners of the Stop TB Partnership, national TB programmes, HIV programmes, local and international NGOs, civil society and community-based organizations can apply for this fast-track funding for early and increased TB case detection among poor, vulnerable and at-risk populations. Click here to read full press release.

Pages

Subscribe to Working Group for New TB Drugs RSS